Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
ENZO BIOCHEM INC incurred convertible notes of $7,608,696 with JGB Collateral, LLC, as collateral agent for the Purchasers at 10% per annum maturing May 20, 2024.
- Instrument
- convertible notes
- Principal
- $7,608,696
- Counterparty
- JGB Collateral, LLC, as collateral agent for the Purchasers
- Rate
- 10% per annum
- Maturity
- May 20, 2024
- Event
- incurrence
Exact text from the filing
the Company agreed to sell to the Purchasers (i) 10% Original Issue Discount Secured Convertible Debentures (the “Debentures”) with an aggregate principal amount of $7,608,696
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
ENZO BIOCHEM INC entered into Securities Purchase Agreement with JGB Collateral, LLC, as collateral agent, and the purchasers that are parties thereto valued at aggregate principal amount of $7,608,696 and ... total purchase price of $7,000,000 (effective 2023-05-19).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- JGB Collateral, LLC, as collateral agent, and the purchasers that are parties thereto
- Value
- aggregate principal amount of $7,608,696 and ... total purchase price of $7,000,000
- Effective
- 2023-05-19
Exact text from the filing
On May 19, 2023, Enzo Biochem, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers that are parties thereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”) and JGB Collateral, LLC, a Delaware limited liability company, as collateral agent for the Purchasers (the “Agent”).
View on SEC.gov